Cargando…

Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol

More than 2,000,000 individuals worldwide have had coronavirus 2019 disease infection (COVID-19), yet there is no effective medical therapy. Multiple off-label and investigational drugs, such as chloroquine and hydroxychloroquine, have gained broad interest due to positive pre-clinical data and are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naksuk, Niyada, Lazar, Sorin, Peeraphatdit, Thoetchai (Bee)
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235441/ https://www.ncbi.nlm.nih.gov/pubmed/32372695 http://dx.doi.org/10.1177/2048872620922784

Ejemplares similares

Current status of liver transplantation for cholangiocarcinoma
por: Twohig, Patrick, et al.
Publicado: (2022)

Gastrointestinal and liver manifestations of COVID-19
por: Cheong, Janice, et al.
Publicado: (2020)

A rash with a heavy heart
por: Barros-Gomes, Sergio, et al.
Publicado: (2017)

Risk Prediction of Nosocomial and Posthospital Discharge Infections in Alcohol‐Associated Hepatitis
por: Penrice, Daniel D., et al.
Publicado: (2021)

Safety Consequences of Off-Label Drugs Used for COVID-19
por: Dasgupta, Nabarun
Publicado: (2021)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Methylphenidate off-label use and safety
por: Trenque, Thierry, et al.
Publicado: (2014)

Off-label intrathecal use of gadobutrol: safety study and comparison of administration protocols
por: Halvorsen, Merete, et al.
Publicado: (2020)

Perioperative changes in left ventricular systolic function following surgical revascularization
por: Downey, Michael C., et al.
Publicado: (2022)

Off-label drugs for weight management
por: Hendricks, Ed J
Publicado: (2017)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

Initial Experience with the BioSig PURE EP™ Signal Recording System: An Animal Laboratory Experience
por: Padmanabhan, Deepak, et al.
Publicado: (2017)

Multiple drugs: Cardiac toxicities following off-label treatment: 3 case reports
Publicado: (2020)

An audit into the monitoring of off-label antipsychotics in primary care
por: Rafi, Damir, et al.
Publicado: (2021)

Evaluation of Charcot Triad, Reynolds Pentad, and Tokyo Guidelines for Diagnosis of Cholangitis Secondary to Choledocholithiasis Across Patient Age Groups
por: Thuluvath, Avesh J., et al.
Publicado: (2021)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

Off label therapies for testosterone replacement
por: DiGiorgio, Lorenzo, et al.
Publicado: (2016)

Safety and Efficacy of Off-label and Unlicensed Medicines in Children
por: Lee, Ji-Hyun, et al.
Publicado: (2018)

Automated Detection of Off-Label Drug Use
por: Jung, Kenneth, et al.
Publicado: (2014)

A tale of two drugs: Off and on-label
por: Narayanan, Raja, et al.
Publicado: (2017)

Multiple drugs: Lack of efficacy during off-label therapy: case report
Publicado: (2021)

Evaluation of off-label medication use and drug safety in a pediatric intensive care unit
por: Lee, Soojin, et al.
Publicado: (2023)

Cardiac adverse reactions with off-label Covid-19 treatments
Publicado: (2020)

Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations
por: Belayneh, Anteneh, et al.
Publicado: (2020)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
por: Simonetti, Oriana, et al.
Publicado: (2021)

Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children
por: Schmiedl, Sven, et al.
Publicado: (2014)

Off-label use of drugs: An evil or a necessity?
por: Gota, Vikram, et al.
Publicado: (2015)

Patterns and predictors of off-label prescription of psychiatric drugs
por: Vijay, Aishwarya, et al.
Publicado: (2018)

Off-label drugs use in pediatric palliative care
por: De Zen, Lucia, et al.
Publicado: (2018)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

Multiple drugs: Drugs ineffective and off-label use: case report
Publicado: (2022)

Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
por: Suwa, Michihiro, et al.
Publicado: (2023)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009)

Chloroquine: Cardiac toxicity following off label use: case report
Publicado: (2021)

Hydroxychloroquine: Cardiac toxicity following off-label use: case report
Publicado: (2021)

Multiple drugs: Haemorrhage and lack of efficacy during off-label therapy: 2 case reports
Publicado: (2021)

Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6jmafoskmvp2pr8gguiuhm9hvq